Pregnancy and microchimerism in autoimmune disease: Protector or insurgent?

Arthritis and Rheumatism

Volumn 46, Issue 2, 2002, Pages 291-297

  Lee Nelson, J ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; DISEASE PREDISPOSITION; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; MICROCHIMERISM; PARITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; CHIMERA; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 0036171159     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.501     Document Type: Review

References (42)

1. Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA
2. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
3. Maternal-fetal immunology and autoimmune disease: Is some autoimmune disease auto-alloimmune or allo-auto-immune?
4. Reproductive function prior to disease onset in women with scleroderma
5. Reproductive factors and the risk of scleroderma: An Italian case-control study
6. Relationship between parity and clinical and biological features in patients with systemic sclerosis
7. Microchimerism and HLA-compatible relationships of pregnancy in SSc
8. Cutting edge: Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: Implications in autoimmunity
9. Microchimerism and HLA relationships of pregnancy: Implications for autoimmune diseases
10. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
11. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma
12. Microchimerism in Japanese women patients with systemic sclerosis
13. Y chromosome microchimerism in rheumatic autoimmune disease
14. Microchimerism in Japanese patients with systemic sclerosis
15. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens
16. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride
17. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis
18. Fetal DNA in skin of polymorphic eruptions of pregnancy
19. Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome
20. Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis
21. Blood fetal microchimerism in primary biliary cirrhosis
22. Fetal microchimerism in primary biliary cirrhosis
23. FISH for Y chromosome in women with primary biliary cirrhosis: Lack of evidence for leukocyte microchimerism
24. Detection of male DNA in the liver of female patients with primary biliary cirrhosis
25. Evidence of fetal microchimerism in Hashimoto's thyroiditis
26. Microchimerism of presumed fetal origin in adult female thyroid specimens
27. Chimerism and autoimmunity
28. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation
29. Neonatal lupus
30. Microchimerism of maternal origin persists into adult life
31. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis
32. HLA-DQA1*0501 is associated with diffuse systemic sclerosis in caucasian men
33. Chimerism in children with juvenile dermatomyositis
34. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies
35. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life
36. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis
37. The onset of rheumatoid arthritis in relation to pregnancy and childbirth
38. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis
39. Transient increase in the risk of breast cancer after giving birth
40. Can stem cells cross lineage boundaries?